The results show that the consumption of quinoa significantly attenuated the clinical symptoms in the DSS-induced colitis model when compared to the condition in the mice fed the AIN-93M control diet, as indicated by reduced body weight loss, better disease activity index, less histological colon damage, and improved inflammatory status (lower plasma IL-6 level). The gene discussed is IL6; the disease is colitis.